Group One Trading’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $450K | Buy |
131,090
+50,319
| +62% | +$173K | ﹤0.01% | 697 |
|
|
2025
Q1 | $180K | Sell |
80,771
-8,433
| -9% | -$18.8K | ﹤0.01% | 849 |
|
|
2024
Q4 | $261K | Buy |
89,204
+14,220
| +19% | +$41.7K | ﹤0.01% | 818 |
|
|
2024
Q3 | $195K | Buy |
74,984
+56,009
| +295% | +$146K | ﹤0.01% | 703 |
|
|
2024
Q2 | $56.2K | Sell |
18,975
-13,800
| -42% | -$40.8K | ﹤0.01% | 966 |
|
|
2024
Q1 | $148K | Buy |
32,775
+11,101
| +51% | +$50.3K | ﹤0.01% | 720 |
|
|
2023
Q4 | $124K | Sell |
21,674
-37,450
| -63% | -$214K | ﹤0.01% | 853 |
|
|
2023
Q3 | $272K | Buy |
59,124
+55,913
| +1,741% | +$257K | ﹤0.01% | 670 |
|
|
2023
Q2 | $20.7K | Sell |
3,211
-13,434
| -81% | -$86.8K | ﹤0.01% | 1197 |
|
|
2023
Q1 | $126K | Sell |
16,645
-40,444
| -71% | -$305K | ﹤0.01% | 791 |
|
|
2022
Q4 | $578K | Buy |
57,089
+45,777
| +405% | +$464K | ﹤0.01% | 506 |
|
|
2022
Q3 | $112K | Sell |
11,312
-61,976
| -85% | -$614K | ﹤0.01% | 985 |
|
|
2022
Q2 | $781K | Buy |
+73,288
| New | +$781K | ﹤0.01% | 493 |
|
|
2022
Q1 | – | Sell |
-84,531
| Closed | -$1.21M | – | 1980 |
|
|
2021
Q4 | $1.21M | Buy |
+84,531
| New | +$1.21M | ﹤0.01% | 615 |
|
|
2021
Q3 | – | Sell |
-19,222
| Closed | -$423K | – | 2017 |
|
|
2021
Q2 | $423K | Buy |
+19,222
| New | +$423K | ﹤0.01% | 863 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1801 |
|